Patent Foramen Ovale Closure Devices Market

DelveInsight’s ‘Patent Foramen Ovale (PFO) Closure Devices- Market Insight, Competitive Landscape and Market Forecast, 2026’ report delivers an in-depth understanding of Patent Foramen Ovale Closure Devices and the historical and forecasted Patent Foramen Ovale Closure Devices market trends in the US, EU5 (Germany, Spain, Italy, France and United Kingdom) and Japan.


The Patent Foramen Ovale (PFO) Closure Devices market report provides an overview of Patent Foramen Ovale Closure Devices, its cause, signs and symptoms, pathophysiology, diagnosis and currently available therapies. Additionally, this report covers the overview, various treatment practices, and patent foramen ovale closure devices forecasted epidemiology from 2018 to 2026, segmented by the seven major markets. The report also covers the market drivers, market barriers and unmet medical needs to curate best of the opportunities and assesses underlying potential of the market.

Patent Foramen Ovale (PFO) Closure Devices Understanding

Patent Foramen Ovale Closure Devices Overview

The term patent foramen oval explains an open/unimpeded foramen ovale. During the fetal development of the baby inside the womb, there is an opening in between the right and the left atrium of the heart. The opening of the foramen oval sustains until the baby comes out, as it is an essential chunk of the fetal circulatory system. Hence, it aids in unobstructed oxygen rich-blood flow from the right to the left atria. The problem arises when the flap-like region (the foramen oval) does not close back. It is supposed to shut back as soon as the baby comes out due to the pressure generated on the left atria after it starts to breathe using its lungs. This hole allows blood to bypass the fetal lungs, which cannot work until they are exposed to air. When a newborn enters the world and takes its first breath, the foramen ovale closes, and within a few months, it has sealed completely in about 75% of the population.


When it remains open, it is called a patent foramen ovale (PFO, patent meaning open). Even though blood is leaking from the right atrium to the left, it is not a problem for the vast majority of the millions of people with a PFO. However, problems can arise when that blood contains a blood clot. 

Geography Covered

  • The US
  • EU5 (Germany, France, Italy, Spain and the United Kingdom)
  • Japan


Study Period: 2018–2026

List of Companies:

  • Abbott Vascular
  • W.L. Gore & Associates, Inc.
  • Starway Medical Technology Inc.
  • OCCLUTECH GMBH
  • Comed BV
  • Cardia Inc.
  • Lifetech Scientific Corporation
  • Heartstitch Inc.
  • PFM Medical AG
  • Lepu Medical Technology

More companies in the report…

Patent Foramen Ovale (PFO) Closure Devices- Competitive Analysis

This segment of the report provides a brief competitive analysis of Patent Foramen Ovale (PFO) Closure Devices to help understand the competition in the market. It gives a comparative understanding of the products based on parameters such as type of regulatory approval.


Patent Foramen Ovale (PFO) Closure Devices: Eligible Patient Population

This segment of the report provides an analysis of the eligible patient pool that incorporate Patent Foramen Ovale (PFO) Closure Devices for their treatment, across 7MM during the study period (2018 and 2026).

Patent Foramen Ovale (PFO) Closure Devices: Market Analysis

This segment illustrates the market of Patent Foramen Ovale (PFO) Closure Devices across 7MM and how the market is expected to rise in the study period (2018 to 2026), at a CAGR of XX%.


Patent Foramen Ovale (PFO) Closure Devices: Market Drivers and Barriers

The report provides insights into the market driving factors and the barriers shaping the Patent Foramen Ovale (PFO) Closure Devices market.


Market Drivers:

  • Prevalence of PFO
  • Escalating preferences for minimally-invasive procedures, which is simple, safer, technically-feasible and effective, less-time consuming surgery


Market Barriers:

  • Post-operational complexities, recurrent stroke, TIA, residual shunting after implantation
  • A smaller number of Clinical Trials
  • Insufficient PFP closure devices

KOL- Views

To keep up with the market trends, we take KOLs and SME’s opinion working in patent foramen ovale closure devices domain through primary research to fill the data gaps and validate our secondary research. Their opinion helps to understand and validate current and emerging therapies treatment patterns or patent foramen ovale closure devices market trend. This will support the clients in making informed business decisions by identifying the overall scenario of the market and the unmet needs.

Scope of the Report

  • The report covers the descriptive overview of Patent Foramen Ovale (PFO) Closure Devices explaining its causes, signs and symptoms, pathophysiology, diagnosis and currently available therapies.
  • Comprehensive insight has been provided into the epidemiology of the Patent Foramen Ovale (PFO) Closure Devices and its treatment in the 7MM
  • Additionally, a complete account of both the current and emerging treatment for Patent Foramen Ovale (PFO) Closure Devices is provided, along with the assessment of new therapies, which is likely to have an impact on the current market landscape.
  • A detailed review of Patent Foramen Ovale (PFO) Closure Devices market; historical and forecasted market size is included in the report, covering devices outreach in the 7MM.
  • The report provides an edge while developing business strategies, by understanding trends shaping and driving the global Patent Foramen Ovale (PFO) Closure Devices market.

Report Highlights

  • The report covers descriptive overview of Patent Foramen Ovale (PFO) Closure Devices, explaining its causes, signs and symptoms, pathophysiology, diagnosis and currently available therapies.
  • The report provides an insight into the patient population eligible for Patent Foramen Ovale (PFO) Closure Devices in the 7MM, covering the US, EU5 (Germany, Spain, France, Italy, UK) & Japan.
  • The report is a comprehensive account of marketed devices present in the Patent Foramen Ovale (PFO) Closure Devices market.
  • The report also reviews the detailed global historical and forecasted Patent Foramen Ovale (PFO) Closure Devices market including assessing the outreach in 7MM.
  • The report helps in developing business strategies by understanding trends shaping and driving the global Patent Foramen Ovale (PFO) Closure Devices market.

Patent Foramen Ovale (PFO) Closure Devices Report Key Strengths

  • 6 Years Forecast
  • 7MM Coverage 
  • Competitive Landscape
  • Patient pool
  • Market Size

Patent Foramen Ovale (PFO) Closure Devices Report Assessment

  • Marketed Product profiles
  • Key Products and Key Players
  • Market Drivers and Barriers
  • Market Forecast
  • KOL’S views
  • PEST Analysis

Key Questions

Market Insights:

  • What was the Patent Foramen Ovale (PFO) Closure Devices market share (%) distribution in 2018 and how it will look like in 2026?
  • What are the key findings pertaining to the market across 7MM and which country will have the largest Patent Foramen Ovale (PFO) Closure Devices market size during the forecast period (2018–2026)?
  • At what CAGR, the Patent Foramen Ovale (PFO) Closure Devices market is expected to grow in 7MM during the forecast period (2018–2026)?
  • What will be the Patent Foramen Ovale (PFO) Closure Devices market outlook across the 7MM during the forecast period (2018–2026)?
  • What will be the Patent Foramen Ovale (PFO) Closure Devices market growth till 2026 and what will be the resultant market size in the year 2026?
  • How will the market drivers, barriers and future opportunities affect the market dynamics and a subsequent analysis of the associated trends?


Competitive Landscape:

  • What are the current devices available in the Patent Foramen Ovale (PFO) Closure Devices market?
  • What is the Patent Foramen Ovale (PFO) Closure Devices available in the market, their product description, regulatory milestones, product development activities, research and development activities etc.?
  • How many key players are developing Patent Foramen Ovale (PFO) Closure Devices?
  • What are the key collaborations (Industry–Industry), Mergers and acquisitions, licensing activities related to the Patent Foramen Ovale (PFO) Closure Devices?
  • What are the key designations that have been granted for the current Patent Foramen Ovale (PFO) Closure Devices?
  • What are the 7MM historical and forecasted market of Patent Foramen Ovale (PFO) Closure Devices?

Frequently Asked Questions

What are Patent Foramen Ovale Closure Devices?

The term patent foramen ovale explains an open/unimpeded foramen ovale. During the fetal development of the baby inside the womb, there is an opening in between the right and the left atrium of the heart.


How is Patent Foramen Ovale Closure Devices Market Segmented?

The Patent Foramen Ovale Closure Devices is segmented on the basis of Product Type, Channel Type and End User.


Who are the leading companies in Patent Foramen Ovale Closure Devices Market Landscape?

The leading companies that are working in the Patent Foramen Ovale Closure Devices Market are Abbott, Vascular W.L. Gore & Associates, Starway Medical Technology Inc, OCCLUTECH GMBH, Comed BV and others.


What are the Patent Foramen Ovale Closure Devices Market Drivers?

Some of the Market Drivers are prevalence of PFO and escalating preferences for minimally-invasive procedures


What are the Patent Foramen Ovale Closure Devices Market Barriers?

Some of the Market Barriers are Post-operational complexities, recurrent stroke, TIA, residual shunting after implantation, smaller number of Clinical Trials and insufficient PFP closure devices


What are the key strengths of Patent Foramen Ovale Closure Devices Market Report?

Key strengths of Patent Foramen Ovale Closure Devices Market Report are 6 Years Forecast, 7MM Coverage, Competitive Landscape, PEST Analysis, Market Size, Market Drivers and Market Barriers.


What is the Impact of Covid-19 on Patent Foramen Ovale Closure Devices Market?

The Patent Foramen Ovale Closure Devices Market has observed a positive shift in market revenues due to the Covid 19 in 2020. The report includes the factors that are contributing to this significant increase in detail.

1 KEY INSIGHTS

2 REPORT INTRODUCTION

3 PATENT FORAMEN OVALE (PFO) CLOSURE DEVICES MARKET OVERVIEW AT A GLANCE

3.1 MARKET SHARE (%) DISTRIBUTION OF PFO CLOSURE DEVICES IN 2018

3.2 MARKET SHARE (%) DISTRIBUTION OF PFO CLOSURE DEVICES IN 2026

4. EXECUTIVE SUMMARY OF PATENT FORAMEN OVALE (PFO) CLOSURE DEVICES

5 PATENT FORAMEN OVALE: BACKGROUND AND OVERVIEW

5.1 INTRODUCTION

5.2 ANATOMY AND CAUSES OF THE PATENT FORAMEN OVALE

5.3 DIAGNOSIS IN PFO PATIENTS

5.4 SYMPTOMS AND THE RISK FACTORS ASSOCIATED WITH PATENT FORAMEN OVALE

5.4.1 Migraine

5.4.2 Cryptogenic Stroke, Transient Ischemic Attack (TIA), and Heart Attack due to congenital heart diseases

5.4.3 Decompression Illness

5.4.4 Platypnoea-orthodeoxia Syndrome

5.5 THE TREATMENT OPTIONS AVAILABLE FOR PFO

5.5.1 Blood-thinning and Anticoagulation therapies

5.5.2 Closing the PFO

5.6 ADVANTAGES OF THE PFO OCCLUDER DEVICES FOR PATENT FORAMEN OVALE CLOSURE

5.7 DISADVANTAGES OF THE PFO OCCLUDER DEVICES FOR PATENT FORAMEN OVALE CLOSURE

6 REGULATORY AND REIMBURSEMENT OF PATENT FORAMEN OVALE CLOSURE DEVICES

6.1 REGULATORY APPROVAL FOR THE DEVICES

6.1.1 United States Regulation of Devices

6.1.2 European Regulation of Devices

6.1.3 Japan Regulation of Devices

6.2 REIMBURSEMENT SCENARIO FOR PATENT FORAMEN OVALE CLOSURE DEVICE

6.2.1 United States

6.2.2 Europe

6.2.3 Japan

7. MARKETED PRODUCTS

7.1 KEY CROSS COMPETITION

7.2 THE AMPLATZER PFO OCCLUDER

7.2.1 Product Description

7.2.2 Regulatory Milestones

7.2.3 Research and Development

7.2.4 Product Development Activities

7.3 GORE CARDIOFORM SEPTAL OCCLUDER

7.3.1 Product Description

7.3.2 Regulatory Milestones

7.3.3 Research and Development

7.4 THE CARDI-O-FIX SEPTAL OCCLUDER

7.4.1 Product Description

7.4.2 Regulatory Milestones

7.4.3 Research and Development

7.5 THE FIGULLA FLEX II PFO OCCLUDER

7.5.1 Product Description

7.5.2 Regulatory Milestones

7.5.3 Research and Development

7.5.4 Product Development Activities

7.6 THE IRISFIT PFO OCCLUDER

7.6.1 Product Description

7.6.2 Regulatory Milestones

7.6.3 Research and Development

7.7 THE HYPERION PFO OCCLUDER

7.7.1 Product Description

7.7.2 Regulatory Milestones

7.8 THE ULTRASEPT PFO CLOSURE DEVICE

7.8.1 Product Description

7.8.2 Regulatory Milestones

7.8.3 Research and Development

7.9 THE CERAFLEX PFO OCCLUDER

7.9.1 Product Description

7.9.2 Regulatory Milestones

7.9.3 Research and Development

7.10 THE NOBLESTITCH EL SUTURE MEDIATED CLOSURE SYSTEM

7.10.1 Product Description

7.10.2 Regulatory Milestones

7.10.3 Research and Development

7.11 THE NIT OCCLUDER PFO

7.11.1 Product Description

7.11.2 Regulatory Milestones

7.12 THE MEMOPART PATENT FORAMEN OVALE (PFO) OCCLUDER

7.12.1 Product Description

7.12.2 Regulatory Milestones

8. ASSUMPTIONS AND RATIONALE: ELIGIBLE PATIENT POPULATION AND MARKET ANALYSIS FOR PFO CLOSURE DEVICES

9. PFO CLOSURE DEVICES: ELIGIBLE PATIENT POPULATION

9.1 ELIGIBLE PATIENT POPULATION FOR PFO CLOSURE IN THE 7MM

9.2 ELIGIBLE PATIENT POPULATION FOR PFO CLOSURE IN THE UNITED STATES

9.3 ELIGIBLE PATIENT POPULATION FOR PFO CLOSURE IN GERMANY

9.4 ELIGIBLE PATIENT POPULATION FOR PFO CLOSURE IN FRANCE

9.5 ELIGIBLE PATIENT POPULATION FOR PFO CLOSURE IN ITALY

9.6 ELIGIBLE PATIENT POPULATION FOR PFO CLOSURE IN SPAIN

9.7 ELIGIBLE PATIENT POPULATION FOR PFO CLOSURE IN THE UNITED KINGDOM

9.8 ELIGIBLE PATIENT POPULATION FOR PFO CLOSURE IN JAPAN

10. PFO CLOSURE DEVICES: MARKET ANALYSIS

10.1 MARKET SIZE OF PFO CLOSURE DEVICES IN THE 7MM

10.2 MARKET SIZE OF PFO CLOSURE DEVICES IN THE UNITED STATES

10.3 MARKET SIZE OF PFO CLOSURE DEVICES IN GERMANY

10.4 MARKET SIZE OF PFO CLOSURE DEVICES IN FRANCE

10.5 MARKET SIZE OF PFO CLOSURE DEVICES IN ITALY

10.6 MARKET SIZE OF PFO CLOSURE DEVICES IN SPAIN

10.7 MARKET SIZE OF PFO CLOSURE DEVICES IN THE UNITED KINGDOM

10.8 MARKET SIZE OF PFO CLOSURE DEVICES IN JAPAN

11. KOL’S VIEWS

12 MARKET DRIVERS

13 MARKET BARRIERS

14 UNMET NEEDS

15 PEST ANALYSIS

16 APPENDIX

16.1 BIBLIOGRAPHY

16.2 REPORT METHODOLOGY

17 DELVEINSIGHT CAPABILITIES

18 DISCLAIMER

19 ABOUT DELVEINSIGHT

List of Table

Table 1: Summary of Patent Foramen Ovale (PFO) Closure Devices, Market, Eligible Patient Pool, and Key Events (2018-2030)

Table 2: Commonly used drugs in the treatment of PFO

Table 3: Key cross of Marketed Drugs

Table 4: Clinical Trials Description: Amplatzer PFO Occluder

Table 5: Clinical Trials Description: GORE CARDIOFORM Septal Occluder

Table 6: Clinical Trials Description: Amplatzer PFO Occluder

Table 7: Eligible Patient Population for PFO Closure in the 7MM (2018–2026)

Table 8: Eligible Patient Population for PFO Closure in the United States (2018–2026)

Table 9: Eligible Patient Population for PFO Closure in Germany (2018–2026)

Table 10: Eligible Patient Population for PFO Closure in France (2018-2026)

Table 11: Eligible Patient Population for PFO Closure in Italy (2018–2026)

Table 12: Eligible Patient Population for PFO Closure in Spain (2018–2026)

Table 13: Eligible Patient Population for PFO Closure in the UK (2018–2026)

Table 14: Eligible Patient Population for PFO Closure in Japan (2018–2026)

Table 15: Market Size of PFO Closure Devices in the 7MM in USD Million (2018–2026)

Table 16: Market Size of PFO Closure Devices in the US in USD Million (2018–2026)

Table 17: Market Size of PFO Closure Devices in Germany in USD Million (2018–2026)

Table 18: Market Size of PFO Closure Devices in France in USD Million (2018-2026)

Table 19: Market Size of PFO Closure Devices in Italy in USD Million (2018–2026)

Table 20: Market Size of PFO Closure Devices in Spain in USD Million (2018-2026)

Table 21: Market Size of PFO Closure Devices in the UK in USD Million (2018-2026)

Table 22: Market Size of PFO Closure Devices in Japan in USD Million (2018-2026)

List of Figures

Figure 1: Class III Device Approval Processes in the United States

Figure 2: Approval Processes in European Countries

Figure 3: Class III Device Approval Processes in Japan

Figure 4: Healthcare reimbursement system in the US

Figure 5: Product Specifications of the Amplatzer PFO Device

Figure 6: The Gore Cardioform Septal Occluder

Figure 7: Cardi-O-Fix Septal Occluder

Figure 8: Product Specifications of the Figulla Flex II PFO Occluder Device

Figure 9: The IrisFIT PFO Occluder

Figure 10: The Hyperion PFO Occluder

Figure 11: The Ultrasept PFO Occluder

Figure 12: The CeraFlex PFO Occluder

Figure 13: The Noblestitch EL Suture mediated closure system

Figure 14: The Nit Occluder PFO

Figure 15: The MemoPart Patent Foramen Ovale Occluder

Figure 16: Eligible Patient Population for PFO Closure in the 7MM (2018–2026)

Figure 17: Eligible Patient Population for PFO Closure in the United States (2018–2026)

Figure 18: Eligible Patient Population for PFO Closure in Germany (2018–2026)

Figure 19: Eligible Patient Population for PFO Closure in France (2018-2026)

Figure 20: Eligible Patient Population for PFO Closure in Italy (2018–2026)

Figure 21: Eligible Patient Population for PFO Closure in Spain (2018–2026)

Figure 22: Eligible Patient Population for PFO Closure in the United Kingdom (2018–2026)

Figure 23: Eligible Patient Population for PFO Closure in Japan (2018-2026)

Figure 24: Market Size of PFO Closure Devices in the 7MM in USD Million (2018–2026)

Figure 25: Market Size of PFO Closure Devices in the United States in USD Million (2018-2026)

Figure 26: Market Size of PFO Closure Devices in Germany in USD Million (2018-2026)

Figure 27: Market Size of PFO Closure Devices in France in USD Million (2018–2026)

Figure 28: Market Size of PFO Closure Devices in Italy in USD Million (2018-2026)

Figure 29: Market Size of PFO Closure Devices in Spain in USD Million (2018–2026)

Figure 30: Market Size of PFO Closure Devices in the UK in USD Million (2018-2026)

Figure 31: Market Size of PFO Closure Devices in Japan in USD Million (2018-2026)

Figure 32: Market Drivers

Figure 33: Market Barriers

• The Amplatzer PFO Occluder: AGA medicals

• GORE CARDIOFORM Septal Occluder: The W.L. Gore & Associates, Inc.

• The Cardi-O-Fix Septal Occluder: Starway Medical Technology Inc.

• The Figulla Flex II PFO Occluder: OCCLUTECH GMBH

• The Hyperion PFO Occluder: Comed BV

• The Ultrasept PFO closure device: The Cardia Inc.

• The CeraFlex PFO Occluder: The Lifetech Scientific Corporation

• The Noblestitch EL Suture mediated closure system: Heartstitch Inc.

• The Nit Occluder PFO: pfm medical ag

• The MemoPart Patent Foramen Ovale (PFO) Occluder: Lepu Medical Technology

  • Tags:
  • Patent Foramen Ovale (PFO) Closure...
  • Patent Foramen Ovale (PFO) Closure...
  • Patent Foramen Ovale (PFO) Closure...
  • Patent Foramen Ovale (PFO) Closure...

Forward to Friend

Need A Quote